South Korea · Delayed Price · Currency is KRW Kyongbo Pharmaceutical Statistics
Total Valuation
KRX:214390 has a market cap or net worth of KRW 139.14 billion. The enterprise value is 258.62 billion.
| Market Cap | 139.14B |
| Enterprise Value | 258.62B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -0.49% in one year.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | -0.49% |
| Shares Change (QoQ) | +3.01% |
| Owned by Insiders (%) | 17.15% |
| Owned by Institutions (%) | 0.19% |
| Float | 9.13M |
Valuation Ratios
The trailing PE ratio is 58.40.
| PE Ratio | 58.40 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.60, with an EV/FCF ratio of -8.64.
| EV / Earnings | 109.28 |
| EV / Sales | 1.03 |
| EV / EBITDA | 11.60 |
| EV / EBIT | 27.40 |
| EV / FCF | -8.64 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.85.
| Current Ratio | 0.95 |
| Quick Ratio | 0.39 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 6.58 |
| Debt / FCF | -4.14 |
| Interest Coverage | 1.39 |
Financial Efficiency
Return on equity (ROE) is 1.63% and return on invested capital (ROIC) is 1.48%.
| Return on Equity (ROE) | 1.63% |
| Return on Assets (ROA) | 1.25% |
| Return on Invested Capital (ROIC) | 1.48% |
| Return on Capital Employed (ROCE) | 3.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, KRX:214390 has paid 381.97 million in taxes.
| Income Tax | 381.97M |
| Effective Tax Rate | 13.90% |
Stock Price Statistics
The stock price has decreased by -20.03% in the last 52 weeks. The beta is 1.08, so KRX:214390's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -20.03% |
| 50-Day Moving Average | 5,985.40 |
| 200-Day Moving Average | 5,583.78 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 39,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:214390 had revenue of KRW 252.20 billion and earned 2.37 billion in profits. Earnings per share was 99.66.
| Revenue | 252.20B |
| Gross Profit | 93.55B |
| Operating Income | 5.97B |
| Pretax Income | 2.75B |
| Net Income | 2.37B |
| EBITDA | 18.84B |
| EBIT | 5.97B |
| Earnings Per Share (EPS) | 99.66 |
Balance Sheet
The company has 4.41 billion in cash and 123.89 billion in debt, giving a net cash position of -119.48 billion or -4,997.79 per share.
| Cash & Cash Equivalents | 4.41B |
| Total Debt | 123.89B |
| Net Cash | -119.48B |
| Net Cash Per Share | -4,997.79 |
| Equity (Book Value) | 145.28B |
| Book Value Per Share | 6,085.39 |
| Working Capital | -8.91B |
Cash Flow
In the last 12 months, operating cash flow was 6.91 billion and capital expenditures -36.84 billion, giving a free cash flow of -29.93 billion.
| Operating Cash Flow | 6.91B |
| Capital Expenditures | -36.84B |
| Free Cash Flow | -29.93B |
| FCF Per Share | -1,251.93 |
Margins
Gross margin is 37.09%, with operating and profit margins of 2.37% and 0.94%.
| Gross Margin | 37.09% |
| Operating Margin | 2.37% |
| Pretax Margin | 1.09% |
| Profit Margin | 0.94% |
| EBITDA Margin | 7.47% |
| EBIT Margin | 2.37% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.51% |
| Buyback Yield | 0.49% |
| Shareholder Yield | 1.34% |
| Earnings Yield | 1.70% |
| FCF Yield | -21.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:214390 has an Altman Z-Score of 1.73 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.73 |
| Piotroski F-Score | 5 |